Trials / Terminated
TerminatedNCT01680107
D-cycloserine Augmented CBT for Panic Disorder
The Effect of a Single-dose of D-cycloserine on the Basic Effects of Cognitive-behaviour Therapy for Panic Disorder - a Randomized Placebo-controlled Trial
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 33 (actual)
- Sponsor
- University of Oxford · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether d-cycloserine augments the clinical effects of exposure-based cognitive-behaviour therapy for panic disorder.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | d-cycloserine | |
| DRUG | placebo | |
| BEHAVIORAL | cognitive-behaviour therapy |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2017-10-31
- Completion
- 2018-04-30
- First posted
- 2012-09-06
- Last updated
- 2018-05-03
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01680107. Inclusion in this directory is not an endorsement.